CFO THOUGHT LEADER cover image

842: Realizing the Potential of Data at Scale | Ross Muken, CFO, Sophia Genetics

CFO THOUGHT LEADER

00:00

Is Going Public the Only Path?

Going public was not the only path, it could have been an exit or a sale. We were really at a place where there was still some scale up that needed to happen. Getting out of Europe into the US public markets is attractive. I would also say the business was really hitting an inflection point and so timing wise as well for its evolution to a public company. And then lastly, being a publicly traded entity does help, right?

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app